MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

: Trastuzumab deruxtecan

Raw xml | Download


<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="mii-exa-mtb-medication-request-trastuzumab-deruxtecan"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-therapieempfehlung|2027.0.0-ballot.1"/>
  </meta>
  <language value="de"/>
  <text>
    <status value="extensions"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: MedicationRequest mii-exa-mtb-medication-request-trastuzumab-deruxtecan</b></p><a name="de-mii-exa-mtb-medication-request-trastuzumab-deruxtecan"> </a><a name="de-hcmii-exa-mtb-medication-request-trastuzumab-deruxtecan"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-mtb-therapieempfehlung.html">MII PR MTB Therapieempfehlung Systemische Therapie</a> version: 2027.0.0-ballot.1</p></div><p><b>MII EX MTB Empfehlung Priorität</b>: 3</p><p><b>MII EX MTB Empfehlung Evidenzgraduierung</b>: <span title="Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad m1B}">m1B</span></p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://www.ncbi.nlm.nih.gov/pubmed</code>/35665782</p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://www.ncbi.nlm.nih.gov/pubmed</code>/37870536</p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://doi.org</code>/10.1200/JCO.2023.41.17_suppl.LBA3000</p><p><b>status</b>: Draft</p><p><b>intent</b>: Proposal</p><p><b>medication</b>: <span title="Codes:{http://fhir.de/CodeSystem/bfarm/atc L01FD04}">Trastuzumab deruxtecan</span></p><p><b>subject</b>: <a href="Patient-PatientKimMusterperson.html">Kim Musterperson  (no stated gender), DoB: 1956-03-14</a></p><p><b>authoredOn</b>: 2023-03-28</p><p><b>reasonReference</b>: <a href="Condition-PatientKimMusterperson-PrimaryDiagnosis-2.html">Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet</a></p></div>
  </text>
  <extension
             url="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-prioritaet">
    <valuePositiveInt value="3"/>
  </extension>
  <extension
             url="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-evidenzgraduierung">
    <valueCodeableConcept>
      <coding>
        <system
                value="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad"/>
        <code value="m1B"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension
             url="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation">
    <valueIdentifier>
      <system value="http://www.ncbi.nlm.nih.gov/pubmed"/>
      <value value="35665782"/>
    </valueIdentifier>
  </extension>
  <extension
             url="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation">
    <valueIdentifier>
      <system value="http://www.ncbi.nlm.nih.gov/pubmed"/>
      <value value="37870536"/>
    </valueIdentifier>
  </extension>
  <extension
             url="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation">
    <valueIdentifier>
      <system value="http://doi.org"/>
      <value value="10.1200/JCO.2023.41.17_suppl.LBA3000"/>
    </valueIdentifier>
  </extension>
  <status value="draft"/>
  <intent value="proposal"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/atc"/>
      <version value="2025"/>
      <code value="L01FD04"/>
      <display value="Trastuzumab deruxtecan"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/PatientKimMusterperson"/>
  </subject>
  <authoredOn value="2023-03-28"/>
  <reasonReference>🔗 
    <reference value="Condition/PatientKimMusterperson-PrimaryDiagnosis-2"/>
  </reasonReference>
</MedicationRequest>